BLCM

AcronymDefinition
BLCMBusiness Life Cycle Management (software)
BLCMBorehole Logging Calibration Model
BLCMBastide, Le Confort Medical (French retail stores)
BLCMBLind Corner Monitor (drive assist technology)
BLCMBovine Lung-Conditioned Medium (cells)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Also higher in the space following the news are bluebird bio, Bellicum Pharmaceuticals (BLCM) and Cellectis SA (CLLS), which have gained 8%, 5% and 6%, respectively.
* Bellicum Pharmaceuticals (NASDAQ: BLCM) stock hit a new 52-week low of $1.06 to begin trading.
(NASDAQ: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported financial results for the second quarter 2019 and provided an operational update.
Several other companies involved in the development of chimeric antigen receptor T cell, or CAR-T, therapies are also rising following the report, including bluebird bio (BLUE), Bellicum Pharmaceuticals (BLCM) and Cellectis SA (CLLS)...
Several other companies involved in the development of chimeric antigen receptor T cell, or CAR-T, therapies also saw gains following the report, including bluebird bio (BLUE), Bellicum Pharmaceuticals (BLCM) and Cellectis SA (CLLS)...
* Bellicum Pharmaceuticals (NASDAQ: BLCM) shares set a new 52-week low of $1.19.
* Bellicum Pharmaceuticals (NASDAQ: BLCM) shares hit a yearly low of $1.26.
* Bellicum Pharmaceuticals (NASDAQ: BLCM) shares fell to $1.30 on Monday, setting a new 52-week low with a shift of down 3.87%.